Stay updated on Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the history and Revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T21:16:12.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added to the history and the previous revision (v3.4.2) was removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:56:16.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page. The government funding status notice and the prior Revision: v3.4.1 were removed.
    Difference
    0.6%
    Check dated 2026-02-11T06:16:46.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The history shows an added government-funding notice and a new revision tag (v3.4.1) replacing v3.4.0, which are minor metadata updates to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T04:42:34.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    UI improvements include a 'Show glossary' option and explanatory notes that additions and deletions are color-coded in the history view, plus a revision note updating to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-01-28T03:10:42.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page history now includes a new revision entry (v3.3.4) and removes the previous revision (v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:49:14.000Z thumbnail image

Stay in the know with updates to Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.